269 related articles for article (PubMed ID: 24748501)
1. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.
Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY
Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
4. [Promoter region methylation of DNA damage repair genes in human gastric cancer].
Guo H; Yan W; Yang Y; Guo M
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(28):2193-6. PubMed ID: 25331470
[TBL] [Abstract][Full Text] [Related]
5. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042
[TBL] [Abstract][Full Text] [Related]
6. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
Alvarez MC; Santos JC; Maniezzo N; Ladeira MS; da Silva AL; Scaletsky IC; Pedrazzoli J; Ribeiro ML
World J Gastroenterol; 2013 May; 19(20):3043-51. PubMed ID: 23716983
[TBL] [Abstract][Full Text] [Related]
7. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.
Baretti M; Karunasena E; Zahurak M; Walker R; Zhao Y; Pisanic TR; Wang TH; Greten TF; Duffy AG; Gootjes E; Meijer G; Verheul HMW; Ahuja N; Herman JG; Azad NS
Clin Transl Sci; 2021 May; 14(3):954-963. PubMed ID: 33811727
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.
Gao YJ; Xin Y; Zhang JJ; Zhou J
World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281
[TBL] [Abstract][Full Text] [Related]
10. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer.
Hu SL; Huang DB; Sun YB; Wu L; Xu WP; Yin S; Chen J; Jiang XD; Shen G
Med Oncol; 2011 Jun; 28(2):447-54. PubMed ID: 20300977
[TBL] [Abstract][Full Text] [Related]
11. Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer.
Tanaka M; Chang P; Li Y; Li D; Overman M; Maru DM; Sethi S; Phillips J; Bland GL; Abbruzzese JL; Eng C
Clin Cancer Res; 2011 Jul; 17(13):4531-40. PubMed ID: 21551253
[TBL] [Abstract][Full Text] [Related]
12. CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.
Brandes JC; van Engeland M; Wouters KA; Weijenberg MP; Herman JG
Carcinogenesis; 2005 Jun; 26(6):1152-6. PubMed ID: 15760919
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
Yoshida K; Hamai Y; Suzuki T; Sanada Y; Oue N; Yasui W
Anticancer Res; 2006; 26(1A):49-54. PubMed ID: 16475678
[TBL] [Abstract][Full Text] [Related]
16. Stage IV early gastric cancer: two cases with microsatellite instability.
An JY; Choi MG; Noh JH; Kim KM; Kim DS; Sohn TS; Kim S
Langenbecks Arch Surg; 2008 Jan; 393(1):105-9. PubMed ID: 17917741
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
18. CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.
Pelosof L; Yerram SR; Ahuja N; Delmas A; Danilova L; Herman JG; Azad NS
Int J Cancer; 2014 Feb; 134(3):596-605. PubMed ID: 23873170
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.
Shigeyasu K; Nagasaka T; Mori Y; Yokomichi N; Kawai T; Fuji T; Kimura K; Umeda Y; Kagawa S; Goel A; Fujiwara T
PLoS One; 2015; 10(6):e0130409. PubMed ID: 26121593
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
Kupcinskaite-Noreikiene R; Ugenskiene R; Noreika A; Rudzianskas V; Gedminaite J; Skieceviciene J; Juozaityte E
BMC Cancer; 2016 Jan; 16():40. PubMed ID: 26810771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
